HistCite Tip of the DayX
Tip of the day
 Previous Tip Next Tip Close 
Add FileX ?
Use [Browse...] to select a file with bibliography data:
Use wildcard '*' to add more than one file at a time. For example, if you have file1, file2, etc. all in the same folder or directory; first, locate one of the files with the [Browse...] button. Then alter the file path in the box above to include '*' character (eg. file*). Wildcard '?' to blanket only one character works too.
Note: In Windows you can select multiple files and "drag and drop" them onto HistCite icon or shortcut. The program would start and load those files.
29 May 2012
Records: 3229, Authors: 8859, Journals: 678, Cited References: 66673, Words: 4568
Yearly output | Document Type | Language | Institution | Institution with Subdivision | Country
Page 7 of 33: [  1  2  3  4  5  6  7  8  9  10 ]  11   21   31 
#Date / Author / JournalLCSGCSLCRCR
6011101 ARITA C, HOTOKEBUCHI T, MIYAHARA H, ARAI K, SUGIOKA Y, et al.
INHIBITION BY FK506 OF ESTABLISHED LESIONS OF COLLAGEN-INDUCED ARTHRITIS IN RATS
CLINICAL AND EXPERIMENTAL IMMUNOLOGY. 1990 DEC; 82 (3): 456-461 		623332
6021102 WOO J, PROPPER DJ, MACLEOD AM, THOMSON AW
INFLUENCE OF FK506 AND CYCLOSPORINE-A ON ALLOANTIBODY PRODUCTION AND LYMPHOCYTE-ACTIVATION FOLLOWING BLOOD- TRANSFUSION
CLINICAL AND EXPERIMENTAL IMMUNOLOGY. 1990 DEC; 82 (3): 462-468 		27323
6031115 WHITE DJG
FK506 - THE PROMISE AND THE PARADOX
CLINICAL AND EXPERIMENTAL IMMUNOLOGY. 1991 JAN; 83 (1): 1-3 		510425
6041204 BLACKHAM A, GRIFFITHS RJ
THE EFFECT OF FK506 AND CYCLOSPORINE-A ON ANTIGEN-INDUCED ARTHRITIS
CLINICAL AND EXPERIMENTAL IMMUNOLOGY. 1991 NOV; 86 (2): 224-228 		119218
6051364 TAMURA K, WOO J, MURASE N, CARRIERI G, NALESNIK MA, et al.
SUPPRESSION OF AUTOIMMUNE THYROID-DISEASE BY FK-506 - INFLUENCE ON THYROID-INFILTRATING CELLS, ADHESION MOLECULE EXPRESSION AND ANTITHYROGLOBULIN ANTIBODY-PRODUCTION
CLINICAL AND EXPERIMENTAL IMMUNOLOGY. 1993 MAR; 91 (3): 368-375 		312632
6061583 THOMSON AW, FORRESTER JV
THERAPEUTIC ADVANCES IN IMMUNOSUPPRESSION
CLINICAL AND EXPERIMENTAL IMMUNOLOGY. 1994 DEC; 98 (3): 351-357 		07577
6071755 HecklOstreicher B, Binder R, Kirschfink M
Functional activity of the membrane-asssociated complement inhibitor CD59 in a pig-to-human in vitro model for hyperacute xenograft rejection
CLINICAL AND EXPERIMENTAL IMMUNOLOGY. 1995 DEC; 102 (3): 589-595 		07250
6081883 Steptoe RJ, Thomson AW
Dendritic cells and tolerance induction
CLINICAL AND EXPERIMENTAL IMMUNOLOGY. 1996 SEP; 105 (3): 397-402 		1486891
6091996 Stepkowski SM, Tian L, Napoli KL, Ghobrial R, Wang ME, et al.
Synergistic mechanisms by which sirolimus and cyclosporin inhibit rat heart and kidney allograft rejection
CLINICAL AND EXPERIMENTAL IMMUNOLOGY. 1997 APR; 108 (1): 63-68 		177330
6102006 Lord R, Goto S, Vari F, EdwardsSmith C, Chiba S, et al.
Differences in the rate of donor leucocyte migration between natural and drug-assisted tolerance following rat liver transplantation
CLINICAL AND EXPERIMENTAL IMMUNOLOGY. 1997 MAY; 108 (2): 358-365 		261335
#Date / Author / JournalLCSGCSLCRCR
6112253 Sato T, Deiwick A, Raddatz G, Koyama K, Schlitt HJ
Interactions of allogeneic human mononuclear cells in the two-way mixed leucocyte culture (MLC): influence of cell numbers, subpopulations and cyclosporin
CLINICAL AND EXPERIMENTAL IMMUNOLOGY. 1999 FEB; 115 (2): 301-308 		28526
6122336 Pan TL, Goto S, Lin YC, Lord R, Chiang KC, et al.
The Fas and Fas ligand pathways in liver allograft tolerance
CLINICAL AND EXPERIMENTAL IMMUNOLOGY. 1999 OCT; 118 (1): 180-187 		216332
6132879 Moberg L, Korsgren O, Nilsson B
Neutrophilic granulocytes are the predominant cell type infiltrating pancreatic islets in contact with ABO- compatible blood
CLINICAL AND EXPERIMENTAL IMMUNOLOGY. 2005 OCT; 142 (1): 125-131 		025131
6143102 Goldman M, Wood K
Translating transplantation tolerance in the clinic: where are we, where do we go?
CLINICAL AND EXPERIMENTAL IMMUNOLOGY. 2009 MAY; 156 (2): 185-188 		04645
6151737 ANDOH TF, BURDMANN EA, LINDSLEY J, HOUGHTON DC, WILLIAM M, et al.
FUNCTIONAL AND STRUCTURAL CHARACTERISTICS OF EXPERIMENTAL FK-506 NEPHROTOXICITY
CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY. 1995 SEP; 22 (9): 646-654 		4241449
6162356 Platt JL, Nagayasu T
Current status of xenotransplantation
CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY. 1999 DEC; 26 (12): 1026-1032 		013261
6172922 Luk JM, Wong KF
Monoclonal antibodies as targeting and therapeutic agents: Prospects for liver transplantation, hepatitis and hepatocellular carcinoma
CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY. 2006 MAY-JUN; 33 (5-6): 482-488 		011576
6182761 Munakata Y, Saito T, Watanabe T, Fujii H, Morimoto C
Rapid inhibitory effect of Tacrolimus on T cell migration by suppressing CD29-related functions
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY. 2004 MAR-APR; 22 (2): 197-204 		01235
6191168 CHRISTIANS U, RADEKE HH, KOWNATZKI R, SCHIEBEL HM, SCHOTTMANN R, et al.
ISOLATION OF AN IMMUNOSUPPRESSIVE METABOLITE OF FK506 GENERATED BY HUMAN MICROSOME PREPARATIONS
CLINICAL BIOCHEMISTRY. 1991 JUN; 24 (3): 271-275 		92617
6202175 Davenport C, Ildstad ST
The role of the facilitating cell in the establishment of donor chimerism and transplantation tolerance
CLINICAL BIOCHEMISTRY. 1998 JUL; 31 (5): 359-367 		02699
#Date / Author / JournalLCSGCSLCRCR
6212207 Sahota A, Yang M, McDaniel HB, Sidner RA, Book B, et al.
Evaluation of seven PCR-based assays for the analysis of microchimerism
CLINICAL BIOCHEMISTRY. 1998 NOV; 31 (8): 641-645 		417924
622779 CARRUTHERS SG, FREEMAN DJ, KOEGLER JC, HOWSON W, KEOWN PA, et al.
SIMPLIFIED LIQUID-CHROMATOGRAPHIC ANALYSIS FOR CYCLOSPORIN-A, AND COMPARISON WITH RADIOIMMUNOASSAY
CLINICAL CHEMISTRY. 1983; 29 (1): 180-183 		8199314
623848 YATSCOFF RW, RUSH DN, JEFFERY JR
EFFECTS OF SAMPLE PREPARATION ON CONCENTRATIONS OF CYCLOSPORIN-A MEASURED IN PLASMA
CLINICAL CHEMISTRY. 1984; 30 (11): 1812-1814 		24319
624994 CLARDY CW, SCHROEDER TJ, MYRE SA, WADHWA NK, PESCE AJ, et al.
CLINICAL VARIABILITY OF CYCLOSPORINE PHARMACOKINETICS IN ADULT AND PEDIATRIC-PATIENTS AFTER RENAL, CARDIAC, HEPATIC, AND BONE-MARROW TRANSPLANTS
CLINICAL CHEMISTRY. 1988 OCT; 34 (10): 2012-2015 		229620
6251314 CHRISTIANS U, BRAUN F, SCHMIDT M, KOSIAN N, SCHIEBEL HM, et al.
SPECIFIC AND SENSITIVE MEASUREMENT OF FK506 AND ITS METABOLITES IN BLOOD AND URINE OF LIVER-GRAFT RECIPIENTS
CLINICAL CHEMISTRY. 1992 OCT; 38 (10): 2025-2032 		1760429
6261444 WALLEMACQ PE, REDING R
FK506 (TACROLIMUS), A NOVEL IMMUNOSUPPRESSANT IN ORGAN-TRANSPLANTATION - CLINICAL, BIOMEDICAL, AND ANALYTICAL ASPECTS
CLINICAL CHEMISTRY. 1993 NOV; 39 (11): 2219-2228 		138122101
6271576 YATSCOFF RW
LABORATORY SUPPORT FOR TRANSPLANTATION
CLINICAL CHEMISTRY. 1994 NOV; 40 (11B): 2166-2173 		011770
6281577 WIESNER RH
ADVANCES IN DIAGNOSIS, PREVENTION, AND MANAGEMENT OF HEPATIC ALLOGRAFT-REJECTION
CLINICAL CHEMISTRY. 1994 NOV; 40 (11B): 2174-2185 		1191594
6291584 WINKLER M, RINGE B, BAUMANN J, LOSS M, WONIGEIT K, et al.
PLASMA VS WHOLE-BLOOD FOR THERAPEUTIC DRUG-MONITORING OF PATIENTS RECEIVING FK-506 FOR IMMUNOSUPPRESSION
CLINICAL CHEMISTRY. 1994 DEC; 40 (12): 2247-2253 		6471125
6301884 Gonschior AK, Christians U, Winkler M, Linck A, Baumann J, et al.
Tacrolimus (FK506) metabolite patterns in blood from liver and kidney transplant patients
CLINICAL CHEMISTRY. 1996 SEP; 42 (9): 1426-1432 		132931
#Date / Author / JournalLCSGCSLCRCR
6312337 Zhang J, Tong KL, Li PKT, Chan AYW, Yeung CK, et al.
Presence of donor- and recipient-derived DNA in cell-free urine samples of renal transplantation recipients: Urinary DNA chimerism
CLINICAL CHEMISTRY. 1999 OCT; 45 (10): 1741-1746 		3341229
6322575 Lui YYN, Lo YMD
Circulating DNA in plasma and serum: Biology, preanalytical issues and diagnostic applications
CLINICAL CHEMISTRY AND LABORATORY MEDICINE. 2002; 40 (10): 962-968 		015372
6332837 Azhipa O, Kimizuka K, Nakao A, Toyokawa H, Okuda T, et al.
Comparative analysis of the fate of donor dendritic cells and B cells and their influence on alloreactive T cell responses under tacrolimus immunosuppression
CLINICAL IMMUNOLOGY. 2005 FEB; 114 (2): 199-209 		031135
634592 TORISU M, YOSHIDA T, COHEN S
SERUM MIGRATION-INHIBITORY ACTIVITY IN PATIENTS WITH POST-TRANSPLANTATION HEPATIC DYSFUNCTION
CLINICAL IMMUNOLOGY AND IMMUNOPATHOLOGY. 1975; 3 (3): 369-376 		018125
635703 SCHMIDTKE JR, RYNASIEWICZ J, GIFFORD RRM, FERGUSON RM, NAJARIAN JS
INVIVO ELIMINATION OF EQUINE ANTI-LYMPHOCYTE GLOBULIN BY RENAL-ALLOGRAFT RECIPIENTS
CLINICAL IMMUNOLOGY AND IMMUNOPATHOLOGY. 1980; 15 (3): 409-414 		27517
6361186 MIYAHARA H, HOTOKEBUCHI T, ARITA C, ARAI K, SUGIOKA Y, et al.
COMPARATIVE-STUDIES OF THE EFFECTS OF FK506 AND CYCLOSPORINE-A ON PASSIVELY TRANSFERRED COLLAGEN-INDUCED ARTHRITIS IN RATS
CLINICAL IMMUNOLOGY AND IMMUNOPATHOLOGY. 1991 AUG; 60 (2): 278-288 		115635
6371315 LUO HY, CHEN HF, DALOZE P, WU JP
EFFECTS OF RAPAMYCIN ON HUMAN HLA-UNRESTRICTED CELL KILLING
CLINICAL IMMUNOLOGY AND IMMUNOPATHOLOGY. 1992 OCT; 65 (1): 60-64 		021329
6381885 Rao AS, Starzl TE, Demetris AJ, Trucco D, Thomson A, et al.
The two-way paradigm of transplantation immunology
CLINICAL IMMUNOLOGY AND IMMUNOPATHOLOGY. 1996 SEP; 80 (3): S46-S51 		7151930
6391717 KRENTZ AJ, DMITREWSKI J, MAYER D, NATTRASS M
EFFECTS OF IMMUNOSUPPRESSIVE AGENTS ON GLUCOSE-METABOLISM - IMPLICATIONS FOR THE DEVELOPMENT OF POSTTRANSPLANT DIABETES-MELLITUS
CLINICAL IMMUNOTHERAPEUTICS. 1995 AUG; 4 (2): 103-123 		22630159
6401756 SCHROEDER TJ, FIRST MR, GABER AO
MONITORING AND MANAGEMENT OF IMMUNOSUPPRESSION IN PEDIATRIC TRANSPLANT PATIENTS
CLINICAL IMMUNOTHERAPEUTICS. 1995 DEC; 4 (6): 425-444 		059134
#Date / Author / JournalLCSGCSLCRCR
6411832 Jain AB, Fung JJ
Cyclosporin and tacrolimus in clinical transplantation - A comparative review
CLINICAL IMMUNOTHERAPEUTICS. 1996 MAY; 5 (5): 351-373 		51245209
6421867 Delaney CP, Murase N, Starzl TE, Demetris AJ
Prevention of transplant rejection - Can tolerance be achieved with immunosuppressive treatment?
CLINICAL IMMUNOTHERAPEUTICS. 1996 AUG; 6 (2): 89-96 		011659
6431551 SCHUURMAN HJ
MOLECULAR MECHANISMS OF TRANSPLANT REJECTION
CLINICAL INVESTIGATOR. 1994 SEP; 72 (9): 715-718 		01111
6442940 Curtis J
Corticosteroids and kidney transplantation
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY. 2006 SEP; 1 (5): 907-908 		12115
6453092 Naesens M, Kuypers DRJ, Sarwal M
Calcineurin Inhibitor Nephrotoxicity
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY. 2009 FEB; 4 (2): 481-508 		31128383
6463130 Gaston RS
Chronic Calcineurin Inhibitor Nephrotoxicity: Reflections on an Evolving Paradigm
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY. 2009 DEC; 4 (12): 2029-2034 		020555
647849 GRIFFIN PJA, WILLIAMS GT, SALAMAN JR
ANTILYMPHOCYTE GLOBULIN FOR THE TREATMENT OF STEROID NON-RESPONSIVE ACUTE RENAL-ALLOGRAFT REJECTION
CLINICAL NEPHROLOGY. 1984; 21 (2): 115-117 		14510
648883 BEWICK M, RUDGE CJ, MILLER BHR, MONKHOUSE PM, REID KE, et al.
THE USE OF PRESSIMMUNE IN RENAL-TRANSPLANTATION - A 4-YEAR STUDY
CLINICAL NEPHROLOGY. 1985; 23 (4): 173-178 		00929
649913 MAKOWKA L, LOPATIN W, GILAS T, FALK J, PHILLIPS MJ, et al.
PREVENTION OF CYCLOSPORINE (CYA) NEPHROTOXICITY BY SYNTHETIC PROSTAGLANDINS
CLINICAL NEPHROLOGY. 1986; 25: S89-S94 		143310
650914 PROVOOST AP, KAPTEIN L, VANAKEN M
NEPHROTOXICITY OF CYCLOSPORINE-A IN RATS WITH A DIMINISHED RENAL-FUNCTION
CLINICAL NEPHROLOGY. 1986; 25: S162-S167 		18625
#Date / Author / JournalLCSGCSLCRCR
6511561 QURESHI AR, LINDHOLM B, ALVESTRAND A, BERGSTROM J, TOLLEMAR J, et al.
NUTRITIONAL-STATUS, MUSCLE COMPOSITION AND PLASMA AND MUSCLE FREE AMINO-ACIDS IN RENAL-TRANSPLANT PATIENTS
CLINICAL NEPHROLOGY. 1994 OCT; 42 (4): 237-245 		020136
6522076 Chen Y, Baltzan M, George D, Bohm C, Okasha K, et al.
Fate of recurrent acute interstitial cellular rejection in an HLA identical kidney transplant recipient: impact of donor microchimerism
CLINICAL NEPHROLOGY. 1997 NOV; 48 (5): 300-306 		261035
6532397 Margreiter R, Steurer W, Spechtenhauser B, Konigsrainer A
Kidney transplantation together with another solid organ from the same donor - a single-center progress report
CLINICAL NEPHROLOGY. 2000 APR; 53 (4): B38-B43 		00420
6542478 Takahara S, Ota K, Takahashi K, Uchida K, Morozumi K, et al.
Chronic cyclosporin-induced nephropathy
CLINICAL NEPHROLOGY. 2001 JAN; 55 (1): 69-72 		0519
6551818 Furukawa H, Reyes J, AbuElmagd K, Todo S
Clinical intestinal transplantation
CLINICAL NUTRITION. 1996 APR; 15 (2): 45-52 		011654
6561410 KOCOSHIS SA, Tzakis AG, TODO S, REYES J, NOUR B
PEDIATRIC LIVER-TRANSPLANTATION - HISTORY, RECENT INNOVATIONS, AND OUTLOOK FOR THE FUTURE
CLINICAL PEDIATRICS. 1993 JUL; 32 (7): 386-392 		0101159
6571389 FAHR A
CYCLOSPORINE CLINICAL PHARMACOKINETICS
CLINICAL PHARMACOKINETICS. 1993 JUN; 24 (6): 472-495 		42248175
6581757 Venkataramanan R, Swaminathan A, Prasad T, Jain A, Zuckerman S, et al.
Clinical pharmacokinetics of tacrolimus
CLINICAL PHARMACOKINETICS. 1995 DEC; 29 (6): 404-430 		1629136147
6591798 Tsunoda SM, Aweeka FT
The use of therapeutic drug monitoring to optimise immunosuppressive therapy
CLINICAL PHARMACOKINETICS. 1996 FEB; 30 (2): 107-140 		03717310
6601799 Campana C, Regazzi MB, Buggia I, Molinaro M
Clinically significant drug interactions with cyclosporin - An update
CLINICAL PHARMACOKINETICS. 1996 FEB; 30 (2): 141-179 		21308364
#Date / Author / JournalLCSGCSLCRCR
6611809 Friman S, Backman L
A new microemulsion formulation of cyclosporin - Pharmacokinetic and clinical features
CLINICAL PHARMACOKINETICS. 1996 MAR; 30 (3): 181-193 		164250
6622649 Ansari AA, Fett JD, Carraway RE, Mayne AE, Onlamoon N, et al.
Autoimmune mechanisms as the basis for human peripartum cardiomyopathy
CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY. 2002 DEC; 23 (3): 301-324 		028367
6633172 Gleicher N
Does the Immune System Induce Labor? Lessons from Preterm Deliveries in Women with Autoimmune Diseases
CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY. 2010 DEC; 39 (3): 194-206 		124103
6642338 Shaw LM, Holt DW, Keown P, Venkataramanan R, Yatscoff RW
Current opinions on therapeutic drug monitoring of immunosuppressive drugs
CLINICAL THERAPEUTICS. 1999 OCT; 21 (10): 1632-1652 		468678
6651800 Wood KJ
New concepts in tolerance
CLINICAL TRANSPLANTATION. 1996 FEB; 10 (1): 93-99 		317247
6661801 Burlingham WJ
Chimerism after organ transplantation: Is there any clinical significance?
CLINICAL TRANSPLANTATION. 1996 FEB; 10 (1): 110-117 		1020552
6671819 Hariharan S, Alexander JW, Schroeder TJ, First MR
Outcome of cadaveric renal transplantation by induction treatment in the cyclosporine era
CLINICAL TRANSPLANTATION. 1996 APR; 10 (2): 186-190 		013529
6681922 Baan CC, Metselaar HJ, Mol WM, Tilanus HW, IJzermans JMN, et al.
Intragraft IL-4 mRNA expression is associated with down-regulation of liver graft rejection
CLINICAL TRANSPLANTATION. 1996 DEC; 10 (6): 542-549 		219237
6692023 Guttmann RD, Fleming C
Sequential biological immunosuppression. Induction therapy with rabbit antithymocyte globulin
CLINICAL TRANSPLANTATION. 1997 JUN; 11 (3): 185-192 		213528
6702024 Ueda M, Hundrieser J, Hisanaga M, Tanaka K, Wonigeit K, et al.
Development of microchimerism in pediatric patients after living-related liver transplantation
CLINICAL TRANSPLANTATION. 1997 JUN; 11 (3): 193-200 		16281226
#Date / Author / JournalLCSGCSLCRCR
6712025 Hohage H, Arlt M, Bruckner D, Dietl KH, Zidek W, et al.
Effects of cyclosporin A and FK 506 on lipid metabolism and fibrinogen in kidney transplant recipients
CLINICAL TRANSPLANTATION. 1997 JUN; 11 (3): 225-230 		124345
6722051 Cantarovich M, Latter DA, Loertscher R
Treatment of steroid-resistant and recurrent acute cardiac transplant rejection with a short course of antibody therapy
CLINICAL TRANSPLANTATION. 1997 AUG; 11 (4): 316-321 		18442
6732067 Reyes J, Todo S, Green M, Yunis E, Schoner D, et al.
Graft-versus-host disease after liver and small bowel transplantation in a child
CLINICAL TRANSPLANTATION. 1997 OCT; 11 (5): 345-348 		715613
6742254 Saggi BH, Fisher RA, Naar JD, Bu D, Obias V, et al.
Intragraft cytokine expression in tolerant rat renal allografts with rapamycin and cyclosporin immunosuppression
CLINICAL TRANSPLANTATION. 1999 FEB; 13 (1): 90-97 		09324
6752298 Henry ML
Cyclosporine and tacrolimus (FK506): A comparison of efficacy and safety profiles
CLINICAL TRANSPLANTATION. 1999 JUN; 13 (3): 209-220 		2641072
6762415 Jindal RM, Dubernard JM
Towards a specific immunosuppression for pancreas and islet grafts
CLINICAL TRANSPLANTATION. 2000 JUN; 14 (3): 242-245 		110313
6772438 Sahota A, Gao SJ, Hayes J, Jindal RM
Microchimerism and rejection: a meta-analysis
CLINICAL TRANSPLANTATION. 2000 AUG; 14 (4): 345-350 		9142744
6782439 Starzl TE, Murase N
Microchimerism, macrochimerism, and tolerance
CLINICAL TRANSPLANTATION. 2000 AUG; 14 (4): 351-354 		8151934
6792524 Tajik N, Singal DP, Pourmand G, Ebrahimi-Rad M, Radjabzadeh MF, et al.
Prospective study of microchimerism in renal allograft recipients: association between HLA-DR matching, microchimerism and acute rejection
CLINICAL TRANSPLANTATION. 2001 JUN; 15 (3): 192-198 		7151117
6802576 Toki K, Takahara S, Moriyama T, Kyo M, Morozumi K, et al.
Analysis of allograft biopsy specimens from long-term surviving patients with stable renal function: predictive value of long-term graft prognosis
CLINICAL TRANSPLANTATION. 2002; 16: 24-30 		01333
#Date / Author / JournalLCSGCSLCRCR
6812577 Zhang ZH, Ohkohchi N, Sakurada M, Mizuno Y, Miyagi S, et al.
Analysis of urinary donor-derived DNA in renal transplant recipients with acute rejection
CLINICAL TRANSPLANTATION. 2002; 16: 45-50 		112316
6822855 Fukuhara N, Ono Y, Hattori R, Nishiyama N, Yamada S, et al.
The long-term outcome of tacrolimus in cadaveric kidney transplantation from non-heart beating donors
CLINICAL TRANSPLANTATION. 2005 APR; 19 (2): 153-157 		02214
6832856 De Ruvo N, Cucchetti A, Lauro A, Masetti M, Di Benedetto F, et al.
Minimization of immunosuppression with thymoglobuline pre-treatment and HCV recurrence in liver transplantation
CLINICAL TRANSPLANTATION. 2005 APR; 19 (2): 255-258 		02318
6842869 Miyagi M, Ishikawa Y, Mizuiri S, Aikawa A, Ohara T, et al.
Significance of subclinical rejection in early renal allograft biopsies for chronic allograft dysfunction
CLINICAL TRANSPLANTATION. 2005 AUG; 19 (4): 456-465 		020344
6852964 Assi MA, Pulido JS, Peters SG, McCannel CA, Razonable RR
Graft-vs.-host disease in lung and other solid organ transplant recipients
CLINICAL TRANSPLANTATION. 2007 JAN-FEB; 21 (1): 1-6 		2141756
6863003 van Petersen AS, van der Pijl HW, Ringers J, Lemkes HH, de Fijter HW, et al.
Gallstone formation after pancreas and/or kidney transplantation: an analysis of risk factors
CLINICAL TRANSPLANTATION. 2007 SEP-OCT; 21 (5): 651-658 		00548
6873106 Pons JA, Ramirez P, Revilla-Nuin B, Pascual D, Baroja-Mazo A, et al.
Immunosuppression withdrawal improves long-term metabolic parameters, cardiovascular risk factors and renal function in liver transplant patients
CLINICAL TRANSPLANTATION. 2009 JUN-JUL; 23 (3): 329-336 		314926
6883125 Taylor K, Sinha S, Cowie A, Babbs C, Reeve R, et al.
Challenges in diagnosing acute pancreatitis in renal transplant patients
CLINICAL TRANSPLANTATION. 2009 NOV-DEC; 23 (6): 985-989 		00618
6893131 Golling M, Sadeghi M, Zipperle S, Fonouni H, Golriz M, et al.
In vitro cytokine responses in liver transplant recipients treated with cyclosporine A and tacrolimus
CLINICAL TRANSPLANTATION. 2009 DEC; 23: 83-91 		02439
6903132 Mehrabi A, Fonouni H, Ayoub E, Rahbari NN, Muller SA, et al.
A single center experience of combined liver kidney transplantation
CLINICAL TRANSPLANTATION. 2009 DEC; 23: 102-114 		029153
#Date / Author / JournalLCSGCSLCRCR
6913192 Sanchez-Lazaro IJ, Almenar L, Martinez-Dolz L, Buendia-Fuentes F, Aguero J, et al.
A prospective randomized study comparing cyclosporine versus tacrolimus combined with daclizumab, mycophenolate mofetil, and steroids in heart transplantation
CLINICAL TRANSPLANTATION. 2011 JUL-AUG; 25 (4): 606-613 		00629
6923193 Cholongitas E, Shusang V, Germani G, Tsochatzis E, Raimondo ML, et al.
Long-term follow-up of immunosuppressive monotherapy in liver transplantation: tacrolimus and microemulsified cyclosporin
CLINICAL TRANSPLANTATION. 2011 JUL-AUG; 25 (4): 614-624 		02433
6932634 Assmann T, Ruzicka T
New immunosuppressive drugs in dermatology (Mycophenolate mofetil, tacrolimus): Unapproved uses, dosages, or indications
CLINICS IN DERMATOLOGY. 2002 SEP-OCT; 20 (5): 505-514 		010574
694780 WHITE DJG
CYCLOSPORIN-A - CLINICAL-APPLICATIONS AND IMMUNOLOGY
CLINICS IN IMMUNOLOGY AND ALLERGY. 1983; 3 (2): 287-304 		16342
695850 ROGERS AJ, KAHAN BD
MECHANISM OF ACTION AND CLINICAL-APPLICATIONS OF CYCLOSPORIN IN ORGAN-TRANSPLANTATION
CLINICS IN IMMUNOLOGY AND ALLERGY. 1984; 4 (2): 217-258 		12919165
696851 SPINA CA
AZATHIOPRINE AS AN IMMUNE MODULATING DRUG - CLINICAL-APPLICATIONS
CLINICS IN IMMUNOLOGY AND ALLERGY. 1984; 4 (2): 415-446 		0214146
6972975 Siemionow M, Agaoglu G
Tissue transplantation in plastic surgery
CLINICS IN PLASTIC SURGERY. 2007 APR; 34 (2): 251-+ 		057101
6982976 Pidwell DJ, Burns C
The immunology of composite tissue transplantation
CLINICS IN PLASTIC SURGERY. 2007 APR; 34 (2): 303-+ 		27686
6992815 Tochtrop GP, King RW
Target identification strategies in chemical genetics
COMBINATORIAL CHEMISTRY & HIGH THROUGHPUT SCREENING. 2004 NOV; 7 (7): 677-688 		025277
7003081 Linden PK
History of Solid Organ Transplantation and Organ Donation
CRITICAL CARE CLINICS. 2009 JAN; 25 (1): 165-+ 		01024127
Page 7 of 33: [  1  2  3  4  5  6  7  8  9  10 ]  11   21   31